Immune checkpoint inhibitor treatment in patients with oncogene-addicted non-small cell lung cancer (NSCLC): summary of a multidisciplinary round-table discussion

Immune checkpoint inhibitor treatment in patients with oncogene-addicted non-small cell lung cancer (NSCLC): summary of a multidisciplinary round-table discussion

The introduction of targeted treatments and more recently immune checkpoint inhibitors (ICI) to the treatment of metastatic non-small cell lung cancer (NSCLC) has dramatically changed the prognosis of selected patients. For patients with oncogene-addicted metastatic NSCLC harbouring an epidermal gro...

Full description

Bibliographic Details
Main Authors: Nicola Normanno, Matthias Preusser, Julien Mazières, Anna S. Berghoff, Beatriz Bellosillo, Christophe Caux, Adrianus de Langen, Mariano Provencio, Federico Rojo, Jurgen Wolf
Format: Article
Language:English
Published: Elsevier 2019-06-01
Series:ESMO Open
Online Access:https://esmoopen.bmj.com/content/4/3/e000498.full

Internet

https://esmoopen.bmj.com/content/4/3/e000498.full

Similar Items